Avidity Biosciences
RNAM
#1801
Rank
A$16.20 B
Marketcap
A$104.91
Share price
0.00%
Change (1 day)
146.94%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: A$16.20 Billion

As of April 2026 Avidity Biosciences has a market cap of A$16.20 Billion. This makes Avidity Biosciences the world's 1801th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026A$16.20 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$228.06 B 1,307.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$162.29 B 901.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$3.44 B-78.72%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$8.21 B-49.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.19 B-98.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.18 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.74 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$4.42 B-72.71%๐Ÿ‡บ๐Ÿ‡ธ USA